Why technology standards are critical for Quantum-Safe Security

Safeguard Insights

January 10, 2012

Life Sciences Trends for 2012: Healthcare IT, Diagnostics, and Personalized Medicine

This week, Safeguard Scientifics’ life sciences team is in San Francisco attending J.P. Morgan’s 30th Annual Healthcare Conference, one of the healthcare industry’s largest annual meetings.…

Posted by James A. Datin

January 9, 2012

Alverix Technology Key to Landmark Flu Test from BD

In the rush of the holidays, you may have missed some recent news from Safeguard Scientifics’ life sciences partner company Alverix. On December 20, 2011,…

Posted by James A. Datin

December 6, 2011

3 Tips on Valuations and Exits for Emerging Healthcare Companies

Last week, I sat on a panel session at the IMPACT 2011 Venture Summit Mid-Atlantic conference held by the Greater Philadelphia Alliance for Capital and Technologies (PACT)…

Posted by James A. Datin

December 2, 2011

Week in Review: Why Startups Falter, Safeguard’s Strong Track Record, and Swap.com Defines an Industry

Contrary to popular belief, a startup’s success does not solely hinge on the idea, but the leadership and talent that drive the company forward. For…

Posted by John E. Shave III

November 18, 2011

Week in Review: Convergence between Life Sciences and Technology and A Look at New Partner Company Medivo

The convergence between life sciences and technology cannot be ignored. That’s why at Safeguard Scientifics, we consolidated of our life sciences and technology deal teams.…

Posted by John E. Shave III

November 15, 2011

Opportunity in the Migraine Market for NuPathe

Ninety percent of migraine sufferers experience nausea, while 60 percent experience vomiting because of their migraine. As a result, today’s most common migraine treatments that…

Posted by James A. Datin

November 8, 2011

The Developing Pet Generics Market: A Look at New Partner Company Putney

In America, there are more than 171 million dogs and cats in over 71 million households. Ninety-six percent of the drugs approved for these pets…

Posted by James A. Datin

October 7, 2011

Recap: Safeguard Scientifics Investor Day 2011

Earlier this week we held our Fifth Annual Investor Day 2011 where investors and analysts heard presentations from Safeguard executives and  highlighted partner companies on…

Posted by John E. Shave III

September 30, 2011

Safeguard Scientifics Investor Day 2011 is 4 Days Away. RSVP Now!

Safeguard Scientifics Investor Day 2011 is right around the corner. Join executives from Safeguard Scientifics and select partner companies at The Yale Club of New York…

Posted by John E. Shave III

Content